These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17346847)
1. Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancer. Chu DT; Kim SW; Kuo HP; Ozacar R; Salajka F; Krishnamurthy S; Damyanov D; Altug S; Reece WH; Wang L Lung Cancer; 2007 Jun; 56(3):433-43. PubMed ID: 17346847 [TBL] [Abstract][Full Text] [Related]
2. Patient attitudes towards chemotherapy and survival: a prospective observational study in advanced non-small cell lung cancer. Chu DT; Kim SW; Hsu HK; Cok G; Roubec J; Patil S; Damyanov D; West T; Hall B; Altug S Lung Cancer; 2009 Nov; 66(2):250-6. PubMed ID: 19264374 [TBL] [Abstract][Full Text] [Related]
3. Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie). Thomas P; Robinet G; Gouva S; Fournel P; Léna H; Le Caer H; Perol M; Berard H; Bombaron P; Vergnenegre A; Kleisbauer JP; Lung Cancer; 2006 Jan; 51(1):105-14. PubMed ID: 16310886 [TBL] [Abstract][Full Text] [Related]
4. Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer. Ritch P; Rudin CM; Bitran JD; Edelman MJ; Makalinao A; Irwin D; Lilenbaum R; Peterson P; John WJ Lung Cancer; 2006 May; 52(2):173-80. PubMed ID: 16507327 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial. Brodowicz T; Krzakowski M; Zwitter M; Tzekova V; Ramlau R; Ghilezan N; Ciuleanu T; Cucevic B; Gyurkovits K; Ulsperger E; Jassem J; Grgic M; Saip P; Szilasi M; Wiltschke C; Wagnerova M; Oskina N; Soldatenkova V; Zielinski C; Wenczl M; Lung Cancer; 2006 May; 52(2):155-63. PubMed ID: 16569462 [TBL] [Abstract][Full Text] [Related]
6. A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer. Masters GA; Argiris AE; Hahn EA; Beck JT; Rausch PG; Ye Z; Monberg MJ; Bloss LP; Curiel RE; Obasaju CK J Thorac Oncol; 2006 Jan; 1(1):19-24. PubMed ID: 17409822 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer. Abratt RP; Lee JS; Han JY; Tsai CM; Boyer M; Mok T; Kim SW; Lee JS; Brnabic AJ; Reece WH; Lehnert M J Thorac Oncol; 2006 Feb; 1(2):135-40. PubMed ID: 17409842 [TBL] [Abstract][Full Text] [Related]
8. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer. Mazzanti P; Massacesi C; Rocchi MB; Mattioli R; Lippe P; Trivisonne R; Buzzi F; De Signoribus G; Tuveri G; Rossi G; Di Lullo L; Sturba F; Morale D; Catanzani S; Pilone A; Bonsignori M; Battelli T Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316 [TBL] [Abstract][Full Text] [Related]
9. Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. Danson S; Middleton MR; O'Byrne KJ; Clemons M; Ranson M; Hassan J; Anderson H; Burt PA; Fairve-Finn C; Stout R; Dowd I; Ashcroft L; Beresford C; Thatcher N Cancer; 2003 Aug; 98(3):542-53. PubMed ID: 12879472 [TBL] [Abstract][Full Text] [Related]
10. Clinical benefit of gemcitabine plus cisplatin 3-week regimen for patients with advanced non-small cell lung cancer: a prospective observational study. Wang L; Liao ML; Li LY; Wan HY; Xu N; Liu JW; Liang HJ Chin Med J (Engl); 2004 Nov; 117(11):1607-10. PubMed ID: 15569473 [TBL] [Abstract][Full Text] [Related]
11. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study. Kubota K; Kawahara M; Ogawara M; Nishiwaki Y; Komuta K; Minato K; Fujita Y; Teramukai S; Fukushima M; Furuse K; Lancet Oncol; 2008 Dec; 9(12):1135-42. PubMed ID: 19013107 [TBL] [Abstract][Full Text] [Related]
12. Randomized, multicenter, open-label phase II study of gemcitabine plus single-dose versus split-dose carboplatin in the treatment of patients with advanced-stage non-small-cell lung cancer. Schuette W; Blankenburg T; Schneider CP; von Weikersthal LF; Guetz S; Laier-Groeneveld G; Virchow JC; Chemaissani A; Reck M Clin Lung Cancer; 2006 Sep; 8(2):135-9. PubMed ID: 17026815 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated. Chen YM; Perng RP; Lee YC; Shih JF; Lee CS; Tsai CM; Whang-Peng J Ann Oncol; 2002 Jan; 13(1):108-15. PubMed ID: 11863090 [TBL] [Abstract][Full Text] [Related]
14. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group. Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757 [TBL] [Abstract][Full Text] [Related]
15. Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer. Han JY; Lee DH; Song JE; Lee SY; Kim HY; Kim HT; Lee JS Cancer; 2008 Jul; 113(2):388-95. PubMed ID: 18484595 [TBL] [Abstract][Full Text] [Related]
16. Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin. Ceribelli A; Gridelli C; De Marinis F; Fabi A; Gamucci T; Cortesi E; Barduagni M; Antimi M; Maione P; Migliorino MR; Giannarelli D; Cognetti F Cancer; 2003 Jul; 98(2):337-43. PubMed ID: 12872354 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer]. Hu X; Jiao S; Zhang S; Wang Z; Wang M; Huang C; Zheng R; Li K; Wang J; Wang Y; Ouyang X; Lv W; Cheng G; Hu C; Luo R; Sun Y Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):569-75. PubMed ID: 23075680 [TBL] [Abstract][Full Text] [Related]
18. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer. de Castria TB; da Silva EM; Gois AF; Riera R Cochrane Database Syst Rev; 2013 Aug; (8):CD009256. PubMed ID: 23949842 [TBL] [Abstract][Full Text] [Related]
19. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer. Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310 [TBL] [Abstract][Full Text] [Related]
20. Quality of Life Achieved by Carboplatin Plus Etoposide as Third-Line Chemotherapy Compared with Best Supportive Care in Non-Small Cell Lung Cancer Stage IIIB/IV. Maneechawakajorn J; Hathaisanguan S J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S175-81. PubMed ID: 27266233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]